Tumor Angiogenesis: Therapeutic Implications

Vegf and Osteosarcoma

    VEGF expression in Osteosarcoma correlates with Vascular Permeability by dynamic MRI

Article

 Endogenous inhibitors of angiogenesis  

Copper lowering therapy with tetrathiomolybdate as an antiangiogenic strategy in cancer

Treatment of Metastatic Cancer with Tetrathiomolybdate, an Anticopper, Antiangiogenic Agent: Phase I Study  pdf

Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer  pdf

Serum vascular endothelial growth factor as a tumor marker in soft tissue sarcomas

Cancer Protocol. COM

Angiogenesis and Cancer Control: From Concept to Therapeutic Trial

 Inhibition of angiogenesis in cancer patients

Ellagic Acid

Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound

Ellagic Acid

Rat study on Ellagic Acid

Synergistic Effect of low levels of quercetin on ellagic acid

 D-Limonene

 Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign  Phase I/II Clinical Trials Committee

2002 Japan Mammary carcinomas induced in human c-Ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment

2004 China Inhibition of growth and metastasis of human gastric cancer implanted in nude mice by d-limonene.

2004 China   pdf   D-Limonene  Mem. Sloan-Kettering

Interferon-alpha

ATRA and interferon-alpha in the treatment of a patient with resistant metastatic osteosarcoma

(full text) Effects of Interferon Alpha on Vascular Endothelial Growth Factor Gene Transcription and Tumor Angiogenesis

Interferon-alpha: regulatory effects on cell cycle and angiogenesis  

Interferon-alpha enhances the sensitivity of human osteosarcoma cells to etoposide

Interferon alpha 2a down-regulates VEGF expression through PI3 kinase and MAP kinase signaling pathways

Effectiveness of Type I interferons in the treatment of multidrug resistant osteosarcoma cells

 Long-term adjuvant interferon treatment of human osteosarcoma. A pilot study

 Interferon/Controlled study in 3-year survival of patients with osteosarcoma

Mental Side effects of Interferon-alpha Treatment

Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study

 Interferon-alpha side effect profile

Prevention of interferon-alpha associated depression               Alpha-interferon and mental disorders

Interferon alpha-induced depression in chronic hepatitis C patients: comparison between different types of interferon alpha

Interleukin-2 and osteosarcoma

Immunomodulation in a treatment program including pre- and post-operative interleukin-2 and chemotherapy for childhood osteosarcoma

Feasibility of high-dose interleukin-2 in heavily pretreated pediatric cancer patients

Other


Isolation of an anti-angiogenic substance from Agaricus blazei Murill: its antitumor and antimetastatic actions

Effect of Silencing HIF-1alpha by RNA Interference on Expression of Vascular Endothelial Growth Factor in Osteosarcoma Cell Line SaOS-2 under Hypoxia